RESUMO
Fluid collected during sweating is enriched with amino acids derived from the skin's natural moisturising factors and has been termed "faux" sweat. Little is known about sex differences in sweat amino acid composition or whether faux sweat amino acid losses affect nitrogen balance. Faux sweat collected by healthy adults (n = 47) after exercise, and at rest by chronic fatigue patients, was analysed for amino acid composition. Healthy females had higher total amino acid concentrations in sweat (10.5 ± 1.2 mM) compared with healthy males (6.9 ± 0.9 mM). Females had higher levels of 13 amino acids in sweat including serine, alanine and glycine. Higher hydroxyproline and proline levels suggested greater collagen turnover in females. Modelling indicated that with conservative levels of exercise, amino acid losses in females via faux sweat were triple than those predicted for urine, whereas in males they were double. It was concluded that females were more susceptible to key amino acid loss during exercise and/or hot conditions. Females reporting chronic fatigue had higher levels of methionine in faux sweat than healthy females. Males reporting chronic fatigue had higher levels of numerous amino acids in faux sweat compared to healthy males. Higher amino acid loss in faux sweat associated with chronic fatigue could contribute to a hypometabolic state. Depending on activity levels, climatic conditions and gender, amino acid losses in sweat and skin leachate could influence daily protein turnover where periods of continuously high turnover could lead to a negative net nitrogen balance.
Assuntos
Aminoácidos/metabolismo , Colágeno/metabolismo , Exercício Físico/fisiologia , Síndrome de Fadiga Crônica/fisiopatologia , Nitrogênio/metabolismo , Suor/metabolismo , Adolescente , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Fatores Sexuais , Pele/metabolismo , Equilíbrio Hidroeletrolítico , Adulto JovemRESUMO
The Sydney rock oyster, Saccostrea glomerata, has been demonstrated as a useful biomonitor of estrogenic compounds following laboratory exposures, yet its utility in the assessment of estrogenic exposure and effects under field conditions requires investigation. To achieve this aim, S. glomerata were deployed in Newcastle, Australia in the effluent receiving marine waters of Burwood Beach WWTP (Burwood Beach "near", <50 m from outfall and Burwood Beach "far", 100-150 m from outfall) and reference locations (Redhead, Fingal Island 1 and Fingal Island 2) at depths of 4, 8 and 12 m for six weeks. Effluent receiving waters of Burwood Beach WWTP were found to be a suitable impact location, demonstrated via measurement of estrogenic compounds and activity throughout the deployment. Estrogenic compounds were detected (average of combined solids and liquid fractions) at average concentrations of: 1.42 ng/L for estrone, 0.69 ng/L for 17ß estradiol, 3.83 ng/L for estriol (E3), 0.56 ng/L for 17α-ethynylestradiol, 64.2 ng/L for bisphenol A, 7.51 ng/L for 4-nonylphenol and 5.93 ng/L for 4-tert-octylphenol. Total estrogenic activity was estimated at 4.48 ng/L EEQ via the Yeast Estrogen Screen (YES(®)) assay (average of combined solid and liquid fractions). Female vitellogenin gene expression was highest at Burwood Beach locations, yet no significant differences were detected among locations for either sex. Vitellogenin protein was significantly higher (p<0.05) in S. glomerata at Burwood Beach Near compared to reference locations for the 4 and 12 m depths. Increased proportions of females were found at Burwood Beach Near, at 4m depth (p<0.05). Both Burwood Beach locations had higher proportions of mature female gonadal development stages compared to reference locations (p<0.05). Oocyte area was highest at both Burwood Beach locations, but no significant differences were detected among locations. Findings provided further evidence that female S. glomerata may be a suitable candidate species for assessment of effects of estrogenic compounds in Australian waters.
Assuntos
Exposição Ambiental , Estrogênios/farmacologia , Ostreidae/efeitos dos fármacos , Reação em Cadeia da Polimerase em Tempo Real/métodos , Poluentes Químicos da Água/farmacologia , Animais , Cromatografia Líquida de Alta Pressão , Monitoramento Ambiental , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Regulação da Expressão Gênica no Desenvolvimento , Gônadas/efeitos dos fármacos , Gônadas/crescimento & desenvolvimento , Masculino , New South Wales , Oócitos/efeitos dos fármacos , Oócitos/crescimento & desenvolvimento , Ostreidae/crescimento & desenvolvimento , Ostreidae/fisiologia , Esgotos , Razão de Masculinidade , Fatores de Tempo , Vitelogeninas/metabolismoRESUMO
Although mounting evidence suggests exposure to estrogenic contaminants increases vitellogenin production in molluscs, demonstration of dose-response relationships and knowledge of the temporal nature of the vitellogenin response with continual exposure is currently lacking for biomarker utility. To address this knowledge gap, adult Sydney rock oysters, Saccostrea glomerata, were exposed to a range of environmentally relevant concentrations of 17α-ethynylestradiol (EE2) (0, 6.25, 12.5, 25 or 50 ng/l) in seawater under laboratory conditions. Vitellogenin induction and gonadal development was assessed following 4, 21 and 49 days exposure to EE2. Vitellogenin was found to increase in a dose dependent manner with EE2 exposure for females (4 and 49 days) and males (4 and 21 days). Histological examination of gonads revealed a number of individuals exhibited intersex (ovotestis) in 50 ng/l EE2 (after 21 days) and in 6.25 and 12.5 ng/l EE2 (after 49 days). Furthermore, a significant shift towards females was observed following 49 days exposure at 50 ng/l EE2 suggesting estrogenic exposure is capable of facilitating a progression for protandric males from male-intersex-female gametal status. Increases in female vitellogenin (4 days) were predictive of later increases in female developmental stages at 21 days and increases in oocyte area following 49 days. Male vitellogenin (4 days) was predictive of decreased male percentages and lower male developmental stages at 49 days. Vitellogenin in S. glomerata is a predictive biomarker of estrogenic exposure and effect if sampled soon after exposure and at the commencement of a gonadal development cycle.
Assuntos
Etinilestradiol/toxicidade , Gônadas/efeitos dos fármacos , Vitelogeninas/efeitos dos fármacos , Poluentes Químicos da Água/toxicidade , Animais , Biomarcadores/metabolismo , Transtornos do Desenvolvimento Sexual/induzido quimicamente , Relação Dose-Resposta a Droga , Estrogênios/administração & dosagem , Estrogênios/toxicidade , Etinilestradiol/administração & dosagem , Feminino , Gônadas/crescimento & desenvolvimento , Masculino , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Ostreidae/efeitos dos fármacos , Fatores Sexuais , Fatores de Tempo , Vitelogeninas/biossíntese , Poluentes Químicos da Água/administração & dosagemRESUMO
Adult Saccostrea glomerata were exposed to environmentally relevant concentrations of 4-nonylphenol (1microg/L and 100microg/L) and 17alpha-ethynylestradiol (5ng/L and 50ng/L) in seawater over 8 weeks. Exposures were performed to assess effects on vitellogenin induction and gonadal development during reproductive conditioning. Chronic direct estrogenicity within gonadal tissue was assessed via an estrogen receptor-mediated, chemical-activated luciferase reporter gene-expression assay (ER-CALUX). Estradiol equivalents (EEQ) were greatest in the 100microg/L 4-nonylphenol exposure (28.7+/-2.3ng/g tissue EEQ) while 17alpha-ethynylestradiol at concentrations of 50ng/L were 2.2+/-1.5ng/g tissue EEQ. Results suggest 4-nonylphenol may be accumulated in tissue and is partly resistant to biotransformation; maintaining its potential for chronic estrogenic action, while 17alpha-ethynylestradiol, although exhibiting greater estrogenic potency on biological endpoints possibly exerts its estrogenic action before being rapidly metabolised and/or excreted. A novel methodology was developed to assess vitellogenin using high-performance liquid chromatography (HPLC). Exposure to both 17alpha-ethynylestradiol (50ng/L) and 4-nonylphenol (100microg/L) produced increases in vitellogenin for females, whereas males exhibited increases in vitellogenin when exposed to 50ng/L 17alpha-ethynylestradiol only. Females exhibited greater vitellogenin responses than males at 50ng/L 17alpha-ethynylestradiol only. Histological examination of gonads revealed a number of individuals exhibiting intersex (ovotestis) in 50ng/L 17alpha-ethynylestradiol exposures. Male individuals in 1microg/L and 100microg/L 4-nonylphenol exposures and 5ng/L 17alpha-ethynylestradiol were at earlier stages of spermatogenic development than corresponding controls.
Assuntos
Etinilestradiol/toxicidade , Gônadas/efeitos dos fármacos , Ostreidae/efeitos dos fármacos , Fenóis/toxicidade , Vitelogênese/efeitos dos fármacos , Poluentes Químicos da Água/toxicidade , Animais , Transtornos do Desenvolvimento Sexual , Feminino , Masculino , Ostreidae/crescimento & desenvolvimento , Ovário/efeitos dos fármacos , Razão de Masculinidade , Testículo/efeitos dos fármacosRESUMO
This study investigated the biological basis of visual processing disabilities in adults with Chronic Fatigue Syndrome. The study involved 61 adults with symptoms of Chronic Fatigue Syndrome who were screened for visual processing problems (Irlen Syndrome) and divided into two groups according to the severity of symptoms of Irlen Syndrome. Significant variations were identified in blood lipids and urine amino and organic acids of the two groups, which may be indicative of activation of the immune system due to some infective agent. It was suggested that metabolic profiling may help the development of more valid diagnostic categories and allow more investigation of immune system dysfunction as a possible causal factor in a range of learning and behaviour disorders.
Assuntos
Síndrome de Fadiga Crônica/imunologia , Infecções/imunologia , Transtornos da Percepção/imunologia , Percepção Visual , Adulto , Pós-Imagem/fisiologia , Comorbidade , Diagnóstico Diferencial , Síndrome de Fadiga Crônica/diagnóstico , Feminino , Humanos , Hidroxiprolina/urina , Infecções/diagnóstico , Lipídeos/sangue , Masculino , Metilistidinas/urina , Transtornos da Percepção/diagnóstico , Prolina/urina , Síndrome , Percepção Visual/fisiologiaRESUMO
We have demonstrated that certain morphological and biochemical changes occur in chronic fatigue syndrome (CFS) and in rheumatoid arthritis (RA). These changes in RA can be explained by the well-established inappropriate increase in free radical generation. The similar changes in CFS suggest a similar explanation and a possible role for free radicals in the aetiology of this condition.
Assuntos
Eritrócitos/metabolismo , Síndrome de Fadiga Crônica/sangue , 2,3-Difosfoglicerato/sangue , Artrite Reumatoide/sangue , Eritrócitos/ultraestrutura , Feminino , Radicais Livres/sangue , Glutationa/sangue , Humanos , Masculino , Malondialdeído/sangue , Metemoglobina/metabolismoRESUMO
Full blood counts, ESR, CRP, haematinics and markers for oxidative stress were measured for 33 patients diagnosed with chronic fatigue syndrome (CFS) and 27 age and sex matched controls. All participants also completed symptom questionnaires. CFS patients had increases in malondialdehyde (P <0.006), methaemoglobin (P <0.02), mean erythrocyte volume (P <0.02) and 2,3-diphosphoglycerate (P <0.04) compared with controls. Multiple regression analysis found methaemoglobin to be the principal component that differentiated between CFS patients and control subjects. Methaemoglobin was found to be the major component associated with variation in symptom expression in CFS patients (R(2) = 0.99, P <0.00001), which included fatigue, musculoskeletal symptoms, pain and sleep disturbance. Variation in levels of malondialdehyde and 2,3-diphosphoglycerate were associated with variations in cognitive symptoms and sleep disturbance (R(2) = 0.99, P <0.00001). These data suggest that oxidative stress due to excess free radical formation is a contributor to the pathology of CFS and was associated with symptom presentation.
Assuntos
Síndrome de Fadiga Crônica/sangue , Síndrome de Fadiga Crônica/diagnóstico , Testes Hematológicos/estatística & dados numéricos , Estresse Oxidativo/fisiologia , 2,3-Difosfoglicerato/sangue , Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Malondialdeído/sangue , Metemoglobina/análise , Pessoa de Meia-IdadeRESUMO
PURPOSE: To investigate the significance of the various late rectal symptoms that appear after radical prostatic irradiation. PATIENTS AND METHODS: Patients with localised prostate cancer treated between 1987 and 1994 at the Mater Hospital, Newcastle with radical megavoltage irradiation were recalled for examination and to complete a detailed questionnaire concerning late radiation-induced symptoms and their effects on normal daily life. The influence of patient age treatment related variables and acute proctitis symptoms occurring during therapy or the late symptoms recorded were assessed and the relationship between late symptoms and late EORTC/RTOG score and impact on normal daily life were studied. RESULTS: The presence of symptoms of acute proctitis was the only factor to predict any of three late symptoms (urgency, frequency and diarrhoea) and late EORTC/RTOG score in this series (odds ratios: 1.7-2.57, P-values: 0.009-0.0007). Cluster and discriminant function analyses revealed the presence of five subgroups of patients with varying permutations of different late rectal symptoms, including one group with minimal symptoms (P < 0.0001). While bleeding and rectal discharge were the major contributors to late EORTC/RTOG score (P < 0.0001 and 0.04), faecal urgency and bleeding were the most important factors to impact on normal daily life (P < 0.0001 and P < 0.0003). A relatively low concordance was found between late EORTC/RTOG score and the patients' self assessment on the effect of their symptoms on their normal daily lives. Some late symptoms, including bleeding and rectal discharge become less prevalent after 3 years of follow-up with a resulting improvement in EORTC/RTOG score. CONCLUSIONS: There may be more than one late (chronic) proctitis syndrome which may be linked in greater or lesser degrees to acute proctitis symptoms occurring during therapy. Urgency is a common late symptom which often has an important impact on normal daily life and deserves recognition in late normal tissue scoring systems. Assessment of the incidence of bleeding as a measure of late rectal morbidity following prostate irradiation may underestimate the impact of these chronic effects. Confirmatory studies are necessary.
Assuntos
Proctite/etiologia , Neoplasias da Próstata/radioterapia , Idoso , Humanos , Masculino , Lesões por Radiação , Radioterapia/efeitos adversos , Radioterapia de Alta Energia , Doenças Retais/etiologiaRESUMO
The cyanobacterium, Microcystis aeruginosa was exposed to direct sunlight for 3, 6 or 9 h in media containing either low or high concentrations of iron, in order to determine any effects on the composition of volatile odour compounds (VOCs) released under photooxidative conditions. The most abundant VOCs detected included aliphatic hydrocarbons (C15-C21), naphthalene and the terpenoid compounds, beta-cyclocitral, and beta-ionone. Exposure to sunlight and low iron concentrations resulted in a decrease in beta-cyclocitral, beta-ionone, heptadecane and the total VOCs concentration after 9 h with respect to the control cultures. Six VOCs detected in the low iron cells were not detected in any of the high iron cells. However, those VOCs present in the high iron cells, in general, occurred at higher concentrations than the equivalent low iron cells after exposure to the sunlight conditions. Consequently, it was concluded that exposure to both high irradiance and high iron concentrations influenced the VOCs composition in cyanobacteria and this was interpreted to represent a cellular change during the photooxidation-promoting conditions.
Assuntos
Hidrocarbonetos/metabolismo , Ferro/farmacologia , Microcystis/efeitos dos fármacos , Microcystis/efeitos da radiação , Luz Solar , Terpenos/metabolismo , Cinética , Microcystis/metabolismo , OdorantesRESUMO
A study was undertaken to assess the ability of the erythrocyte to protect other tissues against oxidative damage. Radiolabelled (51Cr) human umbilical vein endothelial cells (HUVEC) were incubated with erythrocytes and neutrophils activated with phorbol myristate acetate (PMA). Damage to the endothelial cells was indicated by release of radioactivity into the suspending medium. We found that the co-incubation of HUVEC with an increasing range of erythrocyte concentrations resulted in a dose-dependent reduction in the release of radioactivity. When the ability of superoxide to cross the erythrocyte membrane or the glutathione systems was inhibited, the extent of endothelial cell damage increased. Inhibition of the catalase system did not affect results. It was concluded that the erythrocytes afforded some protection against oxidative damage to the endothelial cells by taking up and deactivating the superoxide ions. This protection depends upon intact erythrocyte antioxidant systems. These data support the hypothesis that erythrocytes can provide antioxidant protection to other tissues in vivo.
Assuntos
Antioxidantes/metabolismo , Endotélio Vascular/metabolismo , Eritrócitos/metabolismo , Neutrófilos/imunologia , Oxidantes/antagonistas & inibidores , Ácido 4-Acetamido-4'-isotiocianatostilbeno-2,2'-dissulfônico/farmacologia , Adulto , Amitrol (Herbicida)/farmacologia , Transporte Biológico , Catalase/antagonistas & inibidores , Catalase/fisiologia , Células Cultivadas , Técnicas de Cocultura , Citotoxicidade Imunológica , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Etilmaleimida/farmacologia , Glutationa/antagonistas & inibidores , Glutationa/fisiologia , Humanos , Ativação de Neutrófilo , Neutrófilos/efeitos dos fármacos , Oxidantes/metabolismo , Oxirredução , Superóxidos/antagonistas & inibidores , Superóxidos/metabolismo , Acetato de Tetradecanoilforbol/farmacologia , Veias UmbilicaisRESUMO
Dihydrofluorouracil (FUH2) is the product of the first rate-limiting step in catabolism of 5-fluorouracil (5-FU), catalyzed by the enzyme dihydropyrimidine dehydrogenase. In humans, more than 80% of administered 5-FU is degraded through this catabolic pathway. The ability to measure FUH2 and 5-FU simultaneously may provide an index of the extent to which 5-FU is catabolized. A sensitive and efficient extraction and HPLC method has been developed for simultaneous measurement of FUH2 and 5-FU in patients' plasma. Trichloroacetic acid precipitation of plasma proteins was followed by extraction into ethyl acetate, evaporation under nitrogen, and reconstitution in phosphate buffer. The extract was analyzed by isocratic chromatography using a C18 reversed-phase column with uv detection at 268 nm (5-FU) and 220 nm (FUH2). The detection limit is 0.005 nmol on column for aqueous standards or 0.20 microM in 1 ml of plasma standards for both compounds. This method can be applied to pharmacokinetic studies of 5-FU in patients and may be useful as a means of assessing the activity of dihydropyrimidine dehydrogenase.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Fluoruracila/análogos & derivados , Fluoruracila/sangue , Neoplasias Esofágicas/tratamento farmacológico , Fluoruracila/uso terapêutico , Cromatografia Gasosa-Espectrometria de Massas , HumanosRESUMO
The potential relationships between chlorinated hydrocarbon contamination in human serum and red/white blood cell profiles were investigated by multivariate techniques to assess the cellular response patterns to high and low organochlorine levels in the serum. Twenty-three healthy control subjects and fourteen patients with unexplained and persistent fatigue were divided on the basis of (a) high or low total organochlorine content, (b) high or low DDE (1,1-dichloro-2,2-bis(p-chlorophenyl) ethene) content, and (c) high or low HCB (hexachlorobenzene) content. Discriminant function analysis revealed that the groups with high organochlorine content had significantly different red/white blood cell profiles compared with the low organochlorine groups ((a) P < 0.017, (b) P < 0.015, and (c) P < 0.0002). As a variable, the percentage of neutrophils was the most important discriminant parameter for differentiating between the high and low total organochlorine groups. Thirteen of the fourteen fatigued patients were characterized as "high total organocholorine content" (P < 0.04). The red cell distribution width was elevated in the high DDE group (P < 0.04) and was the most important discriminant parameter for differentiating between the high and low DDE groups. The percentage of eosinophils and the hemoglobin content were both reduced in the high HCB group (P < 0.009,P < 0.003, respectively) and the percentage of eosinophils was the most important discriminant parameter for differentiating between the high and low HCB groups. Those patients with unexplained and persistent fatigue had significantly higher levels of DDE compared with the controls and had different specific blood cell responses to organochlorines compared with control subjects.
Assuntos
Eritrócitos/metabolismo , Síndrome de Fadiga Crônica/sangue , Hidrocarbonetos Clorados/sangue , Inseticidas/sangue , Leucócitos/metabolismo , Adulto , DDT/sangue , Diclorodifenil Dicloroetileno/sangue , Hexaclorobenzeno/sangue , Humanos , Pessoa de Meia-Idade , Análise de RegressãoRESUMO
Chronic fatigue syndrome (CFS) patients have a urinary metabolite labeled CFSUM1 with increased incidence (P < 0.004) and relative abundance (P < 0.00003). The relative abundances of urinary CFSUM1 and beta-alanine were associated with alterations in metabolite excretion and symptom incidence. In 20 CFS patients and 45 non-CFS subjects, symptom/metabolite associations were investigated by assessing symptom sensitivity and specificity, and symptom indices of total symptom incidence, CFS core symptoms, cognitive, neurological, musculoskeletal, gastrointestinal, infection-related and genitourinary symptom indices, as well as a visual analogue pain scale of average pain intensity. Thirty-three symptoms had significant (P < 0.005) sensitivity and specificity in the CFS patients compared to that in the non-CFS controls. Severe fatigue was the only symptom with 100% sensitivity and specificity and CFSUM1 excretion was the primary metabolite for expression of this symptom. All nine symptom indices had elevated responses in the CFS patients (all P < 0.0000001). Multiple regression analyses indicated that all the symptom indices had significant correlations (R) with changes in the urinary excretion of metabolites (P < 0.0001). CFSUM1 and beta-alanine were the first and second metabolites correlated with the CFS core symptom index and CFSUM1 was primarily associated with infection-related and musculoskeletal indices whereas beta-alanine was primarily associated with gastrointestinal and genitourinary indices. The strong associations of CFSUM1 and beta-alanine with CFS symptom expression provide a molecular basis for developing an objective test for CFS.
Assuntos
Síndrome de Fadiga Crônica/urina , Pirrolidinas/urina , Adolescente , Adulto , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Sensibilidade e EspecificidadeRESUMO
Chronic fatigue syndrome (CFS/ME) is a debilitating fatigue illness that has an unknown etiology. We studied 20 chronic fatigue syndrome (CFS) patients, who complied with the Oxford and American CDC definitions, and 45 non-CFS subjects. Participants completed questionnaires, were clinically examined, and had first morning urine specimens collected, which were screened by gas chromatography-mass spectrometry for changes in metabolite excretion. Multivariate analysis of the urinary metabolite profiles differed significantly in the CFS patients compared to the non-CFS patients (P < 0.004). The CFS patients had increases in aminohydroxy-N-methylpyrrolidine (P < 0.00003, referred to as chronic fatigue symptom urinary marker 1, or CFSUM1), tyrosine (P < 0.02), beta-alanine (P < 0.02), aconitic acid (P < 0.05), and succinic acid (P < 0.05) and reductions in an unidentified urinary metabolite, CFSUM2 (P < 0.0007), alanine (P < 0.005), and glutamic acid (P < 0.02). CFSUM1, beta-alanine, and CFSUM2 were found by discriminant function analysis to be the first, second, and third most important metabolites, respectively for discriminating between CFS and non-CFS subjects. The abundances of CFSUM1 and beta-alanine were positively correlated with symptom incidence (P < 0.01 and P < 0.001, respectively), symptom severity, core CFS symptoms, and SCL-90-R somatization (P < 0.00001), suggesting a molecular basis for CFS.
Assuntos
Síndrome de Fadiga Crônica/urina , Ácido Aconítico/urina , Adolescente , Adulto , Alanina/urina , Aminoácidos/urina , Análise de Variância , Biomarcadores/urina , Síndrome de Fadiga Crônica/fisiopatologia , Síndrome de Fadiga Crônica/psicologia , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Ácido Glutâmico/urina , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Exame Físico , Pirrolidinas/urina , Valores de Referência , Succinatos/urina , Ácido Succínico , Inquéritos e Questionários , Tirosina/urina , beta-Alanina/urinaRESUMO
Pregnant Quackenbush Special mice were exposed to ethanol under semiacute (3.0 g/kg body weight intragastrically, days 7 to 12 of pregnancy), and chronic conditions (15% ethanol in drinking water for 5 weeks before and during pregnancy) to assess whether embryo-fetotoxic actions of the drug involve oxidative stress effects. Effects were monitored both in the maternal system and embryo. Alcohol compromised the maternal system by increasing the generation of lipid peroxides in the liver. It also decreased glutathione and vitamin E levels, and glutathione peroxidase and superoxide dismutase activities in this organ. Glutathione peroxidase activity in the maternal blood decreased. Only minor alcohol-induced changes occurred in the uterine endometrium, including decreased xanthine oxidase and increased gamma-glutamyl transpeptidase. Similarly, only few changes were induced in day-12 embryos by alcohol. In this case, glutathione content and xanthine oxidase activity decreased while glutathione reductase activity increased following exposure to the chronic regime. With the possible exception of the maternal liver where evidence of oxidative damage was detected, these results do not reflect substantial changes in the antioxidant defences of either the pregnant mouse or embryo. However, the changes may contribute to the growth retarding and other fetotoxic effects of alcohol when they are totalled into the multifactorial actions of the drug.
Assuntos
Etanol/toxicidade , Morte Fetal/induzido quimicamente , Estresse Oxidativo , Animais , Endométrio/efeitos dos fármacos , Endométrio/enzimologia , Etanol/administração & dosagem , Feminino , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Peróxidos Lipídicos/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Camundongos , Gravidez , Superóxido Dismutase/metabolismo , Vitamina E/metabolismo , Xantina Oxidase/metabolismo , gama-Glutamiltransferase/metabolismoRESUMO
OBJECTIVE: To determine whether serum levels of chlorinated hydrocarbons are elevated in patients with chronic fatigue syndrome. METHODS: Chlorinated hydrocarbon levels were measured in 22 patients with chronic fatigue syndrome (CFS) (as defined by the Centers for Disease Control [CDC]); in 17 patients with CFS symptoms whose history of exposure to toxic chemicals excluded them from the research definition of CFS; and in 34 non-CFS control subjects matched for age and sex. RESULTS: DDE (1,1-dichloro-2,2-bis (p-chlorophenyl) ethene) was detected in all serum samples at levels over 0.4 ppb. The incidence of hexachlorobenzene (HCB) contamination (> 2.0 ppb) was 45% in the CFS group, compared with 21% in the non-CFS control group (P < 0.05). The CFS group had a significantly higher total organochlorine level (15.9 ppb; SEM, 4.4) than the control group (6.3 ppb; SEM, 1.1; P < 0.05). The toxic exposure group also had a higher mean organochlorine level (13.6 ppb; SEM, 6.2) than the control group, but the difference was not statistically significant. DDE and HCB comprised more than 90% of the total organochlorines measured in each of the groups. CONCLUSION: The results suggest that recalcitrant organochlorines may have an aetiological role in CFS. There were no significant differences in serum organochlorine concentrations between CFS patients and chronic fatigue patients with a history of toxic chemical exposure. Therefore, exclusion of patients from the CDC research definition of CFS on the basis of a reported history of known exposure to toxic chemicals is not valid. The role of low-level organochlorine bioaccumulation in the development of CFS symptoms requires further investigation.
Assuntos
Diclorodifenil Dicloroetileno/efeitos adversos , Síndrome de Fadiga Crônica/induzido quimicamente , Adolescente , Adulto , Idoso , Criança , Diclorodifenil Dicloroetileno/sangue , Exposição Ambiental , Síndrome de Fadiga Crônica/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
The biosynthesis in vivo of a number of amino acids, sugars, and purines in Paracoccus denitrificans grown on either [2,3-13C]succinate or [1,4-13C]succinate was investigated by using gas chromatography-mass spectrometry. The distribution of label in the TCA-cycle-related amino acids indicated that carbon intermediates of energy metabolism were utilized as precursors for the biosynthesis of these amino acids in vivo. The biosynthesis of glycine, serine, phenylalanine and glycerol from labelled succinate in vivo were consistent with phosphoenol pyruvate as an intermediate. A mechanism for the formation of C4, C5 and C6 sugars without the use of fructose-1,6-bisphosphate aldolase (which has not been detected in P. denitrificans) is proposed. The 13C-enrichments of ribose in the bacterium indicate that there are at least three routes of ribose biosynthesis operating during growth on labelled succinate. The probability distribution of labelled purine molecules was successfully predicted for adenine, guanine and adenosine, thus confirming their generally accepted route of biosynthesis in vivo.